A detailed history of Bnp Paribas transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bnp Paribas holds 14,362 shares of BMY stock, worth $774,111. This represents 0.03% of its overall portfolio holdings.

Number of Shares
14,362
Previous 39,463 63.61%
Holding current value
$774,111
Previous $2.03 Billion 99.96%
% of portfolio
0.03%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$51.92 - $59.94 $1.3 Million - $1.5 Million
-25,101 Reduced 63.61%
14,362 $812,000
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $1.13 Million - $1.47 Million
28,453 Added 258.43%
39,463 $2.03 Billion
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $655,712 - $863,260
-16,291 Reduced 59.67%
11,010 $457 Million
Q1 2024

May 01, 2024

BUY
$47.98 - $54.4 $1.31 Million - $1.49 Million
27,301 New
27,301 $1.48 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bnp Paribas Portfolio

Follow Bnp Paribas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas, based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas with notifications on news.